Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B. McInnes, Naveed Sattar, Tanja Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée van der Heijde, Marieke Voshaar, Kevin Winthrop, Angelo Ravelli, Neil Betteridge, Gerd R Burmester, J. W. J. Bijlsma, Vivian P. Bykerk, Roberto Caporali, Ernest Choy, Cătălin Codreanu, Bernard Combe, Mary K. Crow, Maarten de Wit, Paul Emery, Roy Fleischmann, Cem Gabay, Merete Lund Hetland, Kimme L Hyrich, Annamaria Iagnocco, John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Topics & Concepts
MedicineInterleukinInterleukin-1 receptorInterleukin 1βStatement (logic)Blocking (statistics)ImmunologyPharmacologyInternal medicineCytokineStatisticsPolitical scienceLawMathematicsSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders ResearchRheumatoid Arthritis Research and Therapies